Attached files

file filename
8-K - 8-K - AMERICAN SCIENCE & ENGINEERING, INC.a13-26465_38k.htm

EXHIBIT 99.1

 

FOR IMMEDIATE RELEASE

 

American Science and Engineering, Inc. Reports Results for

Third Quarter Fiscal Year 2014

 

·                  Company Declaring Quarterly Dividend of $0.50 per share

·                  New Customers Accounted for 36% of Bookings in Q3

·                  38 ZBVs booked in the Quarter — 700 booked to-date

 

BILLERICA, Mass. — February 5, 2014 — American Science and Engineering, Inc. (NASDAQ: ASEI) (“AS&E”), a leading worldwide supplier of innovative X-ray detection solutions, today reports its financial results for the third quarter of fiscal year 2014 ended December 31, 2013. The Company is reporting revenues of $37.8 million as compared with revenues of $50.8 million for the third quarter of fiscal year 2013, net income of $1.6 million as compared with net income of $6.1 million for the third quarter of fiscal year 2013, and earnings per share of $0.20 as compared with earnings per share of $0.73 for the third quarter of fiscal year 2013.

 

For the first nine months of fiscal year 2014 ended December 31, 2013, the Company is reporting revenues of $124.7 million compared with revenues of $144.4 million for the same period in the prior fiscal year, net income of $11.2 million compared with net income of $16.7 million for the same period in the prior fiscal year, and earnings per share of $1.41 compared with earnings per share of $1.95 for the prior fiscal year.

 

The Company is reporting $43.7 million in bookings for the third quarter of fiscal year 2014 and $119.4 million for the first nine months of fiscal year 2014.  Backlog at December 31, 2013 was $180.9 million.

 

Continuing with its dividend program started in August 2007, the Company is declaring a quarterly cash dividend of $0.50 per share, payable on March 3, 2014 to the holders of record at the close of business on February 18, 2014.

 

“Quarterly results for revenue and EPS were negatively impacted by a sizable shipment that was delayed while in transit to the customer,” said Chuck Dougherty, AS&E’s President and Chief Executive Officer.  “Absent this delay, revenues would have been consistent with previous quarters, as we continue to make excellent progress on our key growth initiatives. New customers accounted for 36% of our third quarter bookings with new clients added in the Middle East, the European Union, North America, and the Commonwealth of Independent States (CIS).  Additionally, we continue to successfully execute on our solid ZBV pipeline in key geographic markets, with six new ZBV customers added and 38 ZBV systems booked in the quarter, including the largest single international ZBV booking in the Company’s history.”

 

Chuck Dougherty, President and Chief Executive Officer, and Ken Galaznik, Senior Vice President, Chief Financial Officer and Treasurer, will host a conference call and simultaneous audio webcast on Wednesday, February 5, 2014 at 8:30 a.m. ET to discuss the results and respond to questions.  To participate in the conference call, please dial 1-877-303-9143 at least 10 minutes prior to its starting time. For international participants, please dial 1-760-536-5194. The conference identification number is 35133713. You will be placed on hold until the conference call is ready to begin.  The live audio webcast can be accessed through the investor relations section of the Company’s website at http://ir.as-e.com/events.cfm.

 

An audio replay of the teleconference will be available, in its entirety, starting Wednesday, February 5, 2014 at 11:30 a.m. ET for a one-week period by dialing 1-855-859-2056. Internationally, please dial 1-404-537-3406. The conference identification number is 35133713. The replay will also be available through the Company’s web site at http://ir.as-e.com/events.cfm.

 



 

About AS&E

 

American Science and Engineering, Inc. (AS&E) is the trusted global provider of threat and contraband detection solutions for ports, borders, military, critical infrastructure, law enforcement, and aviation. With over 50 years of experience, AS&E offers proven, advanced, X-ray inspection systems to combat terrorism, drug smuggling, illegal immigration and trade fraud. AS&E systems are designed in a variety of configurations for cargo and vehicle inspection, parcel inspection, and personnel screening. Using a combination of technologies, these systems provide superior detection capabilities, with high-energy, dual-energy, and Z Backscatter X-rays — pioneered by AS&E. Learn more about AS&E products and technologies at www.as-e.com.

 

Investor Relations Contact:

Annemarie Sadowski

American Science and Engineering, Inc.

asadowski@as-e.com

978-262-8828

 

Public Relations Contact:

 

Dana Harris

Laura Berman

Red Javelin Communications, Inc.

American Science and Engineering, Inc.

dana@redjavelin.com

lberman@as-e.com

978-440-8392

978-262-8713

 

Safe Harbor Statement: The foregoing press release contains statements concerning AS&E’s financial performance, markets and business operations that may be considered “forward-looking” under applicable securities laws.  AS&E wishes to caution readers of this press release that actual results might differ materially from those projected in any forward-looking statements. Factors which might cause actual results to differ materially from those projected in the forward-looking statements contained herein include the following: significant reductions, delays or cancellations (in full or in part) in procurements of the Company’s systems by the United States and other governments; disruption in the supply of any source component incorporated into AS&E’s products; litigation seeking to restrict the use of intellectual property used by the Company; limitations under certain laws on the Company’s ability to protect its own intellectual property; potential product liability claims against the Company; global political trends and events which affect public perception of the threat presented by drugs, explosives and other contraband; global economic developments and the ability of governments and private organizations to fund purchases of the Company’s products to address such threats; the potential insufficiency of Company resources, including human resources, capital, plant and equipment and management systems, to accommodate any future growth; technical problems and other delays that could impact new product development and the Company’s ability to adapt to changes in technology and customer requirements; competitive pressures; lengthy sales cycles both in United States government procurement and procurement abroad;  future delays in federal funding, the market price of the company’s stock prevailing from time to time, the nature of other investment opportunities presented to the company from time to time, the company’s cash flows from operations and market and general economic conditions. These and certain other factors which might cause actual results to differ materially from those projected are detailed from time to time in AS&E’s periodic reports and registration statements filed with the Securities and Exchange Commission, which important factors are incorporated herein by reference. AS&E undertakes no obligation to update forward looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in future operating results, financial condition or business over time. Readers are further advised to review the “Risk Factors” set forth in the Company’s most recent Form 10-Q and Form 10-K, which further detail and supplement the factors described in this Safe Harbor Statement.  Among other disclosures, the Risk Factors disclose risks pertaining to that portion of the Company’s business that is dependent on United States government contracting as well as international customers.

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

December 31,
2013

 

December 31,
2012

 

December 31,
2013

 

December 31,
2012

 

Total net sales and contract revenues

 

$

37,773

 

$

50,803

 

$

124,673

 

$

144,400

 

 

 

 

 

 

 

 

 

 

 

Total cost of sales and contract revenues

 

20,905

 

28,103

 

69,452

 

79,230

 

Gross profit

 

16,868

 

22,700

 

55,221

 

65,170

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

8,396

 

8,280

 

22,718

 

21,173

 

Research and development costs

 

6,139

 

5,242

 

15,725

 

18,862

 

Total operating expenses

 

14,535

 

13,522

 

38,443

 

40,035

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

2,333

 

9,178

 

16,778

 

25,135

 

Interest and other, net

 

11

 

54

 

8

 

159

 

Income before provision for income taxes

 

2,344

 

9,232

 

16,786

 

25,294

 

Provision for income taxes

 

786

 

3,139

 

5,624

 

8,600

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

1,558

 

$

6,093

 

$

11,162

 

$

16,694

 

 

 

 

 

 

 

 

 

 

 

Income per share - Basic

 

$

0.20

 

$

0.74

 

$

1.42

 

$

1.97

 

Income per share - Diluted

 

$

0.20

 

$

0.73

 

$

1.41

 

$

1.95

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares - Basic

 

7,850

 

8,247

 

7,837

 

8,488

 

Weighted average shares - Diluted

 

7,889

 

8,307

 

7,873

 

8,542

 

 

The results of operations reported herein may not be indicative of future financial conditions or results of future operations.

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 (in thousands)

(unaudited)

 

 

 

December 31, 2013

 

March 31, 2013

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

65,965

 

$

40,418

 

Restricted cash and investments

 

14,753

 

12,618

 

Short-term investments, at fair value

 

86,428

 

108,546

 

Accounts receivable, net

 

22,591

 

28,477

 

Unbilled costs and fees

 

2,484

 

4,875

 

Inventories, net

 

50,144

 

48,051

 

Other current assets

 

9,101

 

11,984

 

Total current assets

 

251,466

 

254,969

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

Building, equipment and leasehold improvements, net

 

13,972

 

16,451

 

Restricted cash and investments

 

397

 

899

 

Other assets

 

8,687

 

9,130

 

Total assets

 

$

274,522

 

$

281,449

 

 

 

 

 

 

 

 

 

Liabilities & Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

8,913

 

$

8,371

 

Customer deposits

 

33,131

 

16,199

 

Deferred revenue

 

11,410

 

15,770

 

Other current liabilities

 

19,884

 

28,148

 

Total current liabilities

 

73,338

 

68,488

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

Lease financing liability

 

1,783

 

2,914

 

Other non-current liabilities

 

3,695

 

5,802

 

Total liabilities

 

78,816

 

77,204

 

 

 

 

 

 

 

Stockholders’ equity

 

195,706

 

204,245

 

Total liabilities and stockholders’ equity

 

$

274,522

 

$

281,449

 

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

 

 

For the Nine Months Ended

 

 

 

December 31,
2013

 

December 31,
2012

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

11,162

 

$

16,694

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

3,942

 

3,821

 

Provisions for contracts, inventory and accounts receivable reserves

 

1,233

 

3,503

 

Amortization of bond premium

 

1,192

 

2,151

 

Deferred income taxes

 

1,894

 

152

 

Other

 

 

(59

)

Stock compensation expense (credit)

 

1,527

 

(85

)

 

 

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

5,952

 

(14,907

)

Unbilled costs and fees

 

2,391

 

(859

)

Inventories

 

(3,392

)

453

 

Prepaid expenses and other assets

 

1,432

 

684

 

Accounts payable

 

542

 

(892

)

Accrued income taxes

 

(2,094

)

879

 

Customer deposits

 

16,932

 

9,580

 

Deferred revenue

 

(6,472

)

81

 

Accrued expenses and other liabilities

 

(6,181

)

(296

)

Net cash provided by operating activities

 

30,060

 

20,900

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of short-term investments

 

(47,805

)

(99,719

)

Proceeds from sales and maturities of short-term investments

 

68,755

 

150,514

 

Purchases of property and equipment, net

 

(1,463

)

(2,500

)

Net cash provided by investing activities

 

19,487

 

48,295

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Increase in restricted cash and investments

 

(1,633

)

(1,384

)

Proceeds from exercise of stock options

 

2,889

 

1,079

 

Repurchase of shares of common stock

 

(12,306

)

(45,347

)

Repayment of leasehold financing liability

 

(1,115

)

(1,003

)

Payment of common stock dividend

 

(11,749

)

(12,760

)

Reduction of income taxes paid due to the tax benefit from employee stock option exercises

 

(86

)

 

Net cash used for financing activities

 

(24,000

)

(59,415

)

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

25,547

 

9,780

 

Cash and cash equivalents at beginning of period

 

40,418

 

24,369

 

Cash and cash equivalents at end of period

 

$

65,965

 

$

34,149

 

 

-####-